Dr. Rudolf Napieralski, Manager Research & Development, is also co-founder of Therawis Diagnostics GmbH and is a chemist by training. Rudolf worked previously more than ten years in translational cancer research and several years in commercial biomarker development and genomics services. He gained significant expertise in molecular biology, translational tumor biomarker development, especially for quantitative PCR assays, cancer epigenetics and signal transduction pathways. Rudolf completed an advanced training program “Life Science management” at the ATV GmbH, Munich, gaining insight into business development processes, project management, QC and QA, health care regulations and marketing. His research at the department of obstetrics and gynecology and the Institute of Pathology, Technical University of Munich, focused on conducting and managing clinical tumor biomarker development in national and international clinical trials. Rudolf’s industrial career included positions as Manager R&D for the development of single cell qRT-PCR assays at the GILUPI GmbH and Project Assistant at Eurofins Genomics GmbH (formerly Eurofins Medigenomics GmbH). Dr. Napieralski earned his PhD in Biochemistry in the field of adenosine mediated signal transduction pathways from the Institute of Anthropology and Human Genetics at the Ludwig Maximilians University, Munich.